Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × temsirolimus × 1 year × Clear all

Sponsor

Conditions

Neoplasms 4 Neoplasm Metastasis 3 Sarcoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Breast Neoplasms 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Soft Tissue Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 Recurrence 1 Pharyngeal Neoplasms 1 PRETEXT I Hepatoblastoma 1 Neurofibromatosis 2 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Mesothelial 1 Mouth Neoplasms 1 Melanoma 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Erdheim-Chester Disease 1 Endometrial Adenocarcinoma 1 Endocrine Gland Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1

Interventions

Cyclophosphamide 6 Etoposide 4 Prednisone 3 Doxorubicin 3 romidepsin 2 pembrolizumab 2 etoposide phosphate 2 Vincristine 2 Melphalan 2 Brentuximab Vedotin 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 sodium-iodide symporter 1 ruxolitinib 1 prednylidene 1 glofitamab 1 fludarabine phosphate 1 fludarabine 1 duvelisib 1 deltacortene 1 cemiplimab 1 brincidofovir 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡